Primary Site >> Colorectal Cancer

Gene >> NR1H4

Journal: Electrophoresis. 2003 Nov;24(21):3748-54.
Title: Evaluation of RNA messengers involved in lipid trafficking of human intestinal cells by reverse-transcription polymerase chain reaction with competimer technology and microchip electrophoresis.
Author: Cantafora, Alfredo|Blotta, Ida|Rivabene, Roberto|Pisciotta, Livia|Bertolini, Stefano
PMID: 14613201
Journal: Dig Dis Sci. 2004 Jun;49(6):982-9.
Title: The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer.
Author: De Gottardi, Andrea|Touri, Fethi|Maurer, Christoph A|Perez, Anne|Maurhofer, Olivier|Ventre, Giovanni|Bentzen, Craig L|Niesor, Eric J|Dufour, Jean-Francois
PMID: 15309887
Journal: Anticancer Agents Med Chem. 2008 Jun;8(5):540-63.
Title: Bile acids and derivatives, their nuclear receptors FXR, PXR and ligands: role in health and disease and their therapeutic potential.
Author: Zimber, Amazia|Gespach, Christian
PMID: 18537536
Journal: Am J Physiol Gastrointest Liver Physiol. 2008 Nov;295(5):G996-G1003.
Title: beta-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes.
Author: Sinha, Jyoti|Chen, Frank|Miloh, Tamir|Burns, Robert C|Yu, Zhisheng|Shneider, Benjamin L
PMID: 18772362
Journal: Cancer Res. 2008 Dec 1;68(23):9589-94.
Title: Nuclear bile acid receptor FXR protects against intestinal tumorigenesis.
Author: Modica, Salvatore|Murzilli, Stefania|Salvatore, Lorena|Schmidt, Daniel R|Moschetta, Antonio
PMID: 19047134
Journal: Clin Rev Allergy Immunol. 2009 Feb;36(1):52-61.
Title: Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators?
Author: Beuers, Ulrich|Kullak-Ublick, Gerd A|Pusl, Thomas|Rauws, Erik R|Rust, Christian
PMID: 18751930
Journal: J Pharmacol Exp Ther. 2009 Feb;328(2):469-77.
Title: Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development.
Author: Maran, Rengasamy R M|Thomas, Ann|Roth, Megan|Sheng, Zhonghua|Esterly, Noriko|Pinson, David|Gao, Xin|Zhang, Yawei|Ganapathy, Vadivel|Gonzalez, Frank J|Guo, Grace L
PMID: 18981289
Journal: Carcinogenesis. 2010 Jun;31(6):1100-9.
Title: Sodium taurocholate inhibits intestinal adenoma formation in APCMin/+ mice, potentially through activation of the farnesoid X receptor.
Author: Smith, Darcey L H|Keshavan, Pavitra|Avissar, Uri|Ahmed, Kashif|Zucker, Stephen D
PMID: 20194350
Journal: Biochim Biophys Acta. 2010 Jul;1801(7):683-92.
Title: Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease.
Author: Gadaleta, Raffaella M|van Mil, Saskia W C|Oldenburg, Bas|Siersema, Peter D|Klomp, Leo W J|van Erpecum, Karel J
PMID: 20399894
Journal: Pharmacol Res. 2011 Apr;63(4):259-65.
Title: Tissue-specific function of farnesoid X receptor in liver and intestine.
Author: Zhu, Yan|Li, Fei|Guo, Grace L
PMID: 21211565
Journal: Biochim Biophys Acta. 2011 Aug;1812(8):851-8.
Title: Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-kappaB signaling in the intestine.
Author: Gadaleta, Raffaella M|Oldenburg, Bas|Willemsen, Ellen C L|Spit, Maureen|Murzilli, Stefania|Salvatore, Lorena|Klomp, Leo W J|Siersema, Peter D|van Erpecum, Karel J|van Mil, Saskia W C
PMID: 21540105
Journal: PLoS One. 2011;6(7):e22978.
Title: Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation.
Author: Mencarelli, Andrea|Distrutti, Eleonora|Renga, Barbara|D'Amore, Claudio|Cipriani, Sabrina|Palladino, Giuseppe|Donini, Annibale|Ricci, Patrizia|Fiorucci, Stefano
PMID: 21829567
Journal: PLoS One. 2012;7(10):e48461.
Title: Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.
Author: Peng, Zhongsheng|Raufman, Jean-Pierre|Xie, Guofeng
PMID: 23119029
Journal: PLoS One. 2012;7(10):e43044.
Title: FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model.
Author: Deuschle, Ulrich|Schuler, Julia|Schulz, Andreas|Schluter, Thomas|Kinzel, Olaf|Abel, Ulrich|Kremoser, Claus
PMID: 23056173
Journal: Pharmacol Res. 2012 Nov;66(5):419-27.
Title: Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy.
Author: Martinez-Becerra, P|Monte, I|Romero, M R|Serrano, M A|Vaquero, J|Macias, R I R|Del Rio, A|Grane-Boladeras, N|Jimenez, F|San-Martin, F Gonzalez|Pastor-Anglada, M|Marin, J J G
PMID: 22898327
Journal: Histol Histopathol. 2012 Jul;27(7):835-53.
Title: Farnesoid X Receptor (FXR) from normal to malignant state.
Author: Koutsounas, Ioannis|Giaginis, Constantinos|Theocharis, Stamatios
PMID: 22648540
Journal: J Steroid Biochem Mol Biol. 2012 Oct;132(1-2):41-7.
Title: Involvement of multiple elements in FXR-mediated transcriptional activation of FGF19.
Author: Miyata, Masaaki|Hata, Tatsuya|Yamakawa, Hiroki|Kagawa, Tatehiro|Yoshinari, Kouichi|Yamazoe, Yasushi
PMID: 22561792
Journal: Int J Cancer. 2012 May 15;130(10):2232-9.
Title: Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis.
Author: Lax, Sigurd|Schauer, Georg|Prein, Kurt|Kapitan, Magdalena|Silbert, Dagmar|Berghold, Andrea|Berger, Anton|Trauner, Michael
PMID: 21780109
Journal: Mol Pharm. 2012 Sep 4;9(9):2565-76.
Title: Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins.
Author: Herraez, Elisa|Gonzalez-Sanchez, Ester|Vaquero, Javier|Romero, Marta R|Serrano, Maria A|Marin, Jose J G|Briz, Oscar
PMID: 22800197
Journal: Inflamm Bowel Dis. 2013 Feb;19(2):275-82.
Title: Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia.
Author: Torres, Joana|Bao, Xiuliang|Iuga, Alina C|Chen, Anli|Harpaz, Noam|Ullman, Thomas|Cohen, Benjamin L|Pineton de Chambrun, Guillaume|Asciutti, Stefania|Odin, Joseph A|Sachar, David B|Gaskins, H Rex|Setchell, Kenneth|Colombel, Jean-Frederic|Itzkowitz, Steven
PMID: 23348121
Journal: Cancer Prev Res (Phila). 2013 Nov;6(11):1171-81.
Title: Genes with aberrant expression in murine preneoplastic intestine show epigenetic and expression changes in normal mucosa of colon cancer patients.
Author: Leclerc, Daniel|Levesque, Nancy|Cao, Yuanhang|Deng, Liyuan|Wu, Qing|Powell, Jasmine|Sapienza, Carmen|Rozen, Rima
PMID: 24169962
Journal: Am J Physiol Gastrointest Liver Physiol. 2014 Jan 1;306(1):G48-58.
Title: FXR silencing in human colon cancer by DNA methylation and KRAS signaling.
Author: Bailey, Ann M|Zhan, Le|Maru, Dipen|Shureiqi, Imad|Pickering, Curtis R|Kiriakova, Galina|Izzo, Julie|He, Nan|Wei, Caimiao|Baladandayuthapani, Veerabhadran|Liang, Han|Kopetz, Scott|Powis, Garth|Guo, Grace L
PMID: 24177031
Journal: J Biol Chem. 2014 Oct 10;289(41):28421-32.
Title: Transcriptional regulation of the intestinal nuclear bile acid farnesoid X receptor (FXR) by the caudal-related homeobox 2 (CDX2).
Author: Modica, Salvatore|Cariello, Marica|Morgano, Annalisa|Gross, Isabelle|Vegliante, Maria Carmela|Murzilli, Stefania|Salvatore, Lorena|Freund, Jean-Noel|Sabba, Carlo|Moschetta, Antonio
PMID: 25138215
Journal: Acta Pharm Sin B. 2015 Mar;5(2):135-44.
Title: Bile acid nuclear receptor FXR and digestive system diseases.
Author: Ding, Lili|Yang, Li|Wang, Zhengtao|Huang, Wendong
PMID: 26579439
Journal: J Biol Chem. 2015 Mar 6;290(10):6507-15.
Title: MiR-22-silenced cyclin A expression in colon and liver cancer cells is regulated by bile acid receptor.
Author: Yang, Fan|Hu, Ying|Liu, Hui-Xin|Wan, Yu-Jui Yvonne
PMID: 25596928
Journal: Biochim Biophys Acta. 2015 Jan;1851(1):30-9.
Title: Tissue-specific actions of FXR in metabolism and cancer.
Author: Gadaleta, Raffaella Maria|Cariello, Marica|Sabba, Carlo|Moschetta, Antonio
PMID: 25139561
Journal: J Nutr. 2016 Feb;146(2):236-42.
Title: Inactivation of Adenomatous Polyposis Coli Reduces Bile Acid/Farnesoid X Receptor Expression through Fxr gene CpG Methylation in Mouse Colon Tumors and Human Colon Cancer Cells.
Author: Selmin, Ornella I|Fang, Changming|Lyon, Adam M|Doetschman, Tom C|Thompson, Patricia A|Martinez, Jesse D|Smith, Jeffrey W|Lance, Peter M|Romagnolo, Donato F
PMID: 26609171
Journal: Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G1044-51.
Title: microRNA-192 suppresses the expression of the farnesoid X receptor.
Author: Krattinger, Regina|Bostrom, Adrian|Schioth, Helgi B|Thasler, Wolfgang E|Mwinyi, Jessica|Kullak-Ublick, Gerd A
PMID: 27079614
Journal: Acta Chir Belg. 2016 Aug 10:1-8.
Title: The expanding role of the bile acid receptor farnesoid X in the intestine and its potential clinical implications.
Author: Ceulemans, Laurens J|Canovai, Emilio|Verbeke, Len|Pirenne, Jacques|Farre, Ricard
PMID: 27684270
Journal: Mol Aspects Med. 2017 Aug;56:66-74.
Title: Bile acids and colon cancer: Is FXR the solution of the conundrum?
Author: Gadaleta, Raffaella Maria|Garcia-Irigoyen, Oihane|Moschetta, Antonio
PMID: 28400119
Journal: Cancer Res. 2017 Jun 15;77(12):3352-3363.
Title: Western Diet Deregulates Bile Acid Homeostasis, Cell Proliferation, and Tumorigenesis in Colon.
Author: Dermadi, Denis|Valo, Satu|Ollila, Saara|Soliymani, Rabah|Sipari, Nina|Pussila, Marjaana|Sarantaus, Laura|Linden, Jere|Baumann, Marc|Nystrom, Minna
PMID: 28416481
Journal: Oncotarget. 2017 Jun 28;8(38):63665-63679.
Title: Repression of intestinal transporters and FXR-FGF15 signaling explains bile acids dysregulation in experimental colitis-associated colon cancer.
Author: Cao, Lijuan|Che, Yuan|Meng, Tuo|Deng, Shanshan|Zhang, Jun|Zhao, Min|Xu, Wanfeng|Wang, Dandan|Pu, Zhichen|Wang, Guangji|Hao, Haiping
PMID: 28969019
Journal: Nat Rev Gastroenterol Hepatol. 2018 Feb;15(2):111-128.
Title: Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.
Author: Jia, Wei|Xie, Guoxiang|Jia, Weiping
PMID: 29018272
Journal: Physiol Biochem Zool. 2018 Mar/Apr;91(2):797-813.
Title: On the Evolution of Bile Salts and the Farnesoid X Receptor in Vertebrates.
Author: Frisch, Kim|Alstrup, Aage Kristian Olsen
PMID: 29315013
Journal: PLoS One. 2018 Apr 9;13(4):e0195354.
Title: Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.
Author: Holm, Matilda|Saraswat, Mayank|Joenvaara, Sakari|Ristimaki, Ari|Haglund, Caj|Renkonen, Risto
PMID: 29630649
Journal: Oncol Rep. 2018 Oct;40(4):2067-2078.
Title: Farnesoid X receptor inhibits proliferation of human colorectal cancer cells via the miR135A1/CCNG2 signaling pathway.
Author: Qiao, Pengfei|Li, Shenglong|Zhang, Haogang|Yao, Lei|Wang, Fujing
PMID: 30106441